| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7da9064f16bf42b16a1d6bdfb76d7a7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y107-03003 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate |
2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dede2e4c50d48dcdb43e7c5ebde7ad36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73c99f0982c784ee731cb875c45d159 |
| publicationDate |
2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2011013489-A |
| titleOfInvention |
METHODS AND EQUIPMENT FOR PREDICTING THE RISK OF REACTION TO THE INFUSION AND LOSS OF ANSWER MEDIATION BY ANTIBODIES BY SUPERVISING THE URIC ACID IN SERUM DURING A THERAPY WITH URICASA CONJUGATED WITH PEG. |
| abstract |
Methods and equipment are provided to predict the risk of infusion reaction and loss of antibody-mediated response during intravenous PEG-conjugated uricase therapy in patients with gout. Routine SUA monitoring can be used to identify patients receiving PEG-conjugated uricase who may no longer benefit from treatment and who are at greater risk of infusion reactions. |
| priorityDate |
2009-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |